Growth Metrics

Scholar Rock Holding (SRRK) Short-term Investments (2017 - 2026)

Scholar Rock Holding's quarterly Short-term Investments came in at $49.4 million in Q1 2026, down 78.18% year-on-year from $226.4 million in Q1 2025, and up 12.18% quarter-over-quarter from $44.0 million in Q4 2025.

Scholar Rock Holding has reported Short-term Investments for 10 years, with the latest figure at $49.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Short-term Investments fell 78.18% year-over-year to $49.4 million; the trailing twelve-month figure through Mar 2026 stood at $49.4 million (down 78.18% YoY), and the FY2025 full-year result was $44.0 million, down 83.02% from the prior year.
  • Short-term Investments for Q1 2026 stood at $49.4 million, up from $44.0 million in the prior quarter.
  • The five-year high for Short-term Investments was $259.4 million in Q4 2024, with the low at $44.0 million in Q4 2025.
  • Average Short-term Investments over 5 years is $135.4 million, with a median of $140.7 million recorded in 2023.
  • Year-over-year, Short-term Investments jumped 428.12% in 2022 and slumped 83.02% in 2025.
  • Tracing SRRK's Short-term Investments over 5 years: stood at $212.1 million in 2022, then fell by 16.03% to $178.1 million in 2023, then surged by 45.66% to $259.4 million in 2024, then tumbled by 83.02% to $44.0 million in 2025, then advanced by 12.18% to $49.4 million in 2026.
  • The last three Short-term Investments figures came in at $49.4 million (Q1 2026), $44.0 million (Q4 2025), and $82.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Scholar Rock Holding 500.61 Mn 20.67 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 49.40 Mn
Dec 31, 2025 44.04 Mn
Sep 30, 2025 82.86 Mn
Jun 30, 2025 142.09 Mn
Mar 31, 2025 226.45 Mn
Dec 31, 2024 259.40 Mn
Sep 30, 2024 62.67 Mn
Jun 30, 2024 97.12 Mn
Mar 31, 2024 146.45 Mn
Dec 31, 2023 178.08 Mn
Sep 30, 2023 151.04 Mn
Jun 30, 2023 140.67 Mn
Mar 31, 2023 124.00 Mn
Dec 31, 2022 212.09 Mn
Sep 30, 2022 210.58 Mn
Jun 30, 2022 64.96 Mn
Mar 31, 2022 110.04 Mn
Dec 31, 2021 40.16 Mn
Sep 30, 2021 70.30 Mn
Jun 30, 2021 75.30 Mn
Mar 31, 2021 155.58 Mn
Dec 31, 2020 180.67 Mn
Sep 30, 2020 60.04 Mn
Jun 30, 2020 26.05 Mn
Mar 31, 2020 65.21 Mn
Dec 31, 2019 121.14 Mn
Sep 30, 2019 143.44 Mn
Jun 30, 2019 71.33 Mn
Mar 31, 2019 92.66 Mn
Dec 31, 2018 60.58 Mn
Dec 31, 2017 1.50 Mn